The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Leveraging a robust patient-derived xenograft platform to characterize predictors for engraftment and oncologic outcomes in renal cell carcinoma patients.
 
Nirmish Singla
No Relationships to Disclose
 
Layton Woolford
No Relationships to Disclose
 
Christina Stevens
No Relationships to Disclose
 
Vanina Tcheuyap
No Relationships to Disclose
 
Oreoluwa Onabolu
No Relationships to Disclose
 
Zhiqun Xie
No Relationships to Disclose
 
Renee McKay
No Relationships to Disclose
 
Tao Wang
Employment - Medpace (I)
 
Alana Christie
No Relationships to Disclose
 
Jeffrey Gahan
No Relationships to Disclose
 
Aditya Bagrodia
No Relationships to Disclose
 
Ganesh Raj
Honoraria - Astellas Pharma; Janssen Biotech; Medivation; Sanofi
Speakers' Bureau - Astellas Pharma
Research Funding - Janssen Biotech
 
Arthur I. Sagalowsky
No Relationships to Disclose
 
Yair Lotan
Consulting or Advisory Role - AstraZeneca; Augmenix; BioCancell; MDxhealth; Merck; pacific edge; Photocure; Vessi Medical
Research Funding - Abbott Molecular (Inst); Augmenix; BioCancell (Inst); Cepheid; Cepheid (Inst); GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst); Photocure (Inst)
 
Jeffrey A Cadeddu
Stock and Other Ownership Interests - Titan Medical
Consulting or Advisory Role - AngioDynamics
 
Vitaly Margulis
Honoraria - Astellas Pharma; Bayer; ferring; Genomic Health; Johnson & Johnson; MDxHealth
Speakers' Bureau - Astellas Pharma; Bayer; Ferring; Genomic Health; Johnson & Johnson; MDxHealth
 
Payal Kapur
No Relationships to Disclose
 
James Brugarolas
Consulting or Advisory Role - Nektar
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Patent of HIF-2 biomarker (Inst)
Other Relationship - Nektar